Macrophage-dependent regulation of neurotoxic APP fragments in a model system
模型系统中神经毒性 APP 片段的巨噬细胞依赖性调节
基本信息
- 批准号:8701023
- 负责人:
- 金额:$ 23.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-02-15 至 2016-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAlzheimer&aposs DiseaseAmyloidAmyloid beta-Protein PrecursorAnimalsBehaviorBindingBiochemicalBiologicalBiological AssayBiological AvailabilityBiological MarkersBiological ModelsBlocking AntibodiesBlood - brain barrier anatomyBrainCD36 geneCell DeathCerebrospinal FluidCleaved cellClinicalDataDevelopmentDiseaseEmbryoExpression LibraryFamily memberFutureGenesGenomeGoalsGrowthHome environmentHomingHumanImageImmune responseIn VitroInflammatoryInflammatory ResponseInjuryInsectaLesionManducaManduca sextaMediatingMembrane ProteinsMethodsMicrogliaModelingMononuclearMusNatural ImmunityNerve DegenerationNervous system structureNeurodegenerative DisordersNeuronal InjuryNeuronsOperative Surgical ProceduresOrthologous GenePathway interactionsPatientsPeripheralPhagocytesPhagocytosisPhysiologicalPlasmidsPlayPrimary Cell CulturesProcessProtein FamilyProtein FragmentProteinsProtocols documentationRecruitment ActivityRegulationResearchRoleSenile PlaquesSignal PathwaySignal TransductionSourceSynapsesSystemTestingTraumatic Brain InjuryWorkamyloid peptidebeta-site APP cleaving enzyme 1cell motilitycontactinembryo culturein vivoinhibitor/antagonistinjuredmacrophagemigrationmonocytenerve injuryneurogenesisneuronal growthneurotoxicnew therapeutic targetnovelnovel therapeuticspeptide 32peptide Apreventprotein expressionpublic health relevancereceptorrepairedresponseresponse to injuryscavenger receptorsecretasesynaptogenesistooluptake
项目摘要
DESCRIPTION (provided by applicant): The mechanisms that control the clearance of Amyloid Precursor Protein (APP)-derived fragments in the brain remain poorly understood. APP expression is dramatically upregulated following neuronal injury and in a variety of neurodegenerative diseases, resulting in elevated levels of both amyloid (A?) peptides and soluble sAPP ectodomains that have potent biological activities. Growing evidence suggests that the misregulation of sAPP levels can be harmful to the nervous system, while abnormal sAPP levels may provide useful biomarkers for a variety of neurodegenerative conditions and injury responses. In contrast to extensive work on microglial responses to A?, the mechanisms by which these phagocytic cells regulate sAPP levels in the brain has remained largely unexplored. To address this issue, we have adapted the Lepidopteran species Manduca (a well-characterized model of innate immunity) to investigate the mechanisms of sAPP scavenging. As in humans, insect macrophages actively phagocytose cleaved membrane proteins and cellular debris to protect the nervous system, a process that can be readily analyzed both in vitro and in vivo. Recently, we discovered that Manduca macrophages play a prominent role in removing the shed ectodomains of APPL (the insect ortholog of APP). Both during development and following nerve injury, macrophages home to regions of neuronal migration, growth, and repair, where they phagocytose neuronally derived APPL ectodomains (sAPPLs). Using a plasmid expression library to screen for APPL-binding partners, we identified Manduca Contactin (msContactin) as a candidate sAPPL receptor that is expressed by insect macrophages. Whereas Contactins have traditionally been considered neuronal-specific receptors, we have now shown that both mouse microglia and macrophages also express specific subsets of Contactins, depending on their activation state. Initial trials using blocking
antibodies indicate that msContactin is required for macrophage responses to sAPPLs (but not to A?), suggesting that distinct mechanisms are used to clear different APP fragments. These discoveries suggest a previously unrecognized role for Contactins in mediating non-inflammatory responses to sAPP. Aim 1 will test the hypothesis that msContactin specifically regulates the homing and phagocytic responses of insect macrophages to sAPPL fragments, using our gene knockdown, re-expression, and imaging protocols in primary cell cultures and developing animals. Aim 2 will use primary cultures of mouse microglia and macrophages to test whether Contactin-dependent responses to sAPP represents a novel signaling pathway used by mammalian phagocytic cells. Successful completion of these studies will provide new data for an R01 application, with the goal of comprehensively defining the mechanisms by which Contactin-dependent signaling regulates the microglial control of sAPPs in the nervous system. Public Heath Relevance: Understanding these mechanisms will support new therapeutic strategies for preventing the accumulation of toxic sAPP fragments associated with neurodegenerative disease and traumatic brain injury.
描述(由申请人提供):控制淀粉样蛋白前体蛋白(APP)衍生片段的清除率的机制仍然很熟悉。神经元损伤和多种神经退行性疾病后,APP表达在显着上调,从而导致淀粉样蛋白(A?)肽和可溶性SAPP升高,具有有效的生物学活性。 越来越多的证据表明,SAPP水平的正调可能对神经系统有害,而异常的SAPP水平可能为各种神经退行性疾病和损伤反应提供有用的生物标志物。 与对A的小胶质响应的广泛工作相反,这些吞噬细胞调节大脑中SAPP水平的机制在很大程度上尚未开发。为了解决这个问题,我们已经改编了鳞翅目物种曼达(Manduca)(一种良好的先天免疫模型),以研究SAPP清除的机制。 与人类一样,昆虫巨噬细胞积极地吞噬细胞裂解膜蛋白和细胞碎片以保护神经系统,这一过程很容易在体外和体内进行分析。 最近,我们发现曼达省巨噬细胞在去除Appl(App的昆虫直系同源物)的脱落外域中起着重要作用。 在发育和神经损伤期间,巨噬细胞都源于神经元迁移,生长和修复区域,它们吞噬了神经元的神经元素衍生的appy域(Sappls)。我们使用质粒表达库来筛选Appl结合伴侣,我们确定了曼达卡接触蛋白(Mscontactin)是由昆虫巨噬细胞表达的候选SAPPL受体。传统上,接触蛋白被认为是神经元特异性受体,但我们现在表明,小鼠的小胶质细胞和巨噬细胞也表达了接触蛋白的特定亚群,具体取决于它们的激活状态。 使用阻止的初步试验
抗体表明巨噬细胞对sappls的反应需要mscontactin(但不是?),这表明使用了不同的机制来清除不同的应用片段。这些发现表明,接触蛋白在介导对SAPP的非炎症反应中的作用是没有认可的。 AIM 1将检验以下假设:Mscontactin使用我们的基因敲低,重新表达和在原代细胞培养物和发育动物中的基因敲低,重新表达和成像方案来特异性调节昆虫巨噬细胞对SAPPL片段的归巢和吞噬响应。 AIM 2将使用小鼠小胶质细胞和巨噬细胞的原发性培养物来测试接触蛋白依赖性对SAPP的反应是否代表了哺乳动物吞噬细胞使用的新型信号传导途径。 这些研究的成功完成将为R01应用提供新的数据,目的是全面定义接触蛋白依赖性信号传导调节神经系统中SAPP的小胶质细胞控制的机制。 公共荒地相关性:了解这些机制将支持新的治疗策略,以防止与神经退行性疾病和创伤性脑损伤相关的有毒sapp碎片的积累。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILIP F COPENHAVER其他文献
PHILIP F COPENHAVER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILIP F COPENHAVER', 18)}}的其他基金
Therapeutic targeting a membrane estrogen receptor with a novel non-steroidal compound for Alzheimer's disease
使用新型非甾体化合物靶向膜雌激素受体治疗阿尔茨海默病
- 批准号:
10670490 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
A novel role for receptor tyrosine phosphatase in neuroblast migration
受体酪氨酸磷酸酶在神经母细胞迁移中的新作用
- 批准号:
8464388 - 财政年份:2012
- 资助金额:
$ 23.1万 - 项目类别:
A novel role for receptor tyrosine phosphatase in neuroblast migration
受体酪氨酸磷酸酶在神经母细胞迁移中的新作用
- 批准号:
8355610 - 财政年份:2012
- 资助金额:
$ 23.1万 - 项目类别:
Novel mechanisms of Ephrin-A reverse signaling in neuronal migration
Ephrin-A 神经元迁移中反向信号传导的新机制
- 批准号:
8089002 - 财政年份:2010
- 资助金额:
$ 23.1万 - 项目类别:
ROLE OF APP-RELATED PROTEINS DURING NEURONAL MIGRATION
APP 相关蛋白在神经元迁移过程中的作用
- 批准号:
7476496 - 财政年份:2006
- 资助金额:
$ 23.1万 - 项目类别:
ROLE OF APP-RELATED PROTEINS DURING NEURONAL MIGRATION
APP 相关蛋白在神经元迁移过程中的作用
- 批准号:
7099351 - 财政年份:2006
- 资助金额:
$ 23.1万 - 项目类别:
ROLE OF APP-RELATED PROTEINS DURING NEURONAL MIGRATION
APP 相关蛋白在神经元迁移过程中的作用
- 批准号:
7674549 - 财政年份:2006
- 资助金额:
$ 23.1万 - 项目类别:
ROLE OF APP-RELATED PROTEINS DURING NEURONAL MIGRATION
APP 相关蛋白在神经元迁移过程中的作用
- 批准号:
7687102 - 财政年份:2006
- 资助金额:
$ 23.1万 - 项目类别:
ROLE OF APP-RELATED PROTEINS DURING NEURONAL MIGRATION
APP 相关蛋白在神经元迁移过程中的作用
- 批准号:
7258855 - 财政年份:2006
- 资助金额:
$ 23.1万 - 项目类别:
ROLE OF APP-RELATED PROTEINS DURING NEURONAL MIGRATION
APP 相关蛋白在神经元迁移过程中的作用
- 批准号:
7920108 - 财政年份:2006
- 资助金额:
$ 23.1万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 23.1万 - 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 23.1万 - 项目类别: